electroCore Investor Relations Material
Latest events
Q3 2024
electroCore
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from electroCore Inc
Access all reports
electroCore Inc is a commercial-stage medical technology company that develops and markets non-invasive neuromodulation devices. Its primary product, a handheld device, uses electrical stimulation to target the vagus nerve for the treatment of various conditions, including migraines and cluster headaches. The company’s technology is designed to offer patients a non-drug, non-invasive alternative for pain management and neurological disorders. electroCore is also exploring the potential use of its platform in other therapeutic areas such as respiratory diseases and inflammatory conditions. The company is headquartered in Rockaway, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
ECOR
Country
🇺🇸 United States